Extra-Virgin Olive Oil Phenolics in IBD-Associated Vascular Risk
Molecules · 26.05.2026 · 31 (11) · 1827
DOI: 10.3390/molecules31111827 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 26.05.2026. Verfasst von Roko Šantić und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, University of Split School of Medicine, 21000 Split, Croatia. Hauptthemen laut MEDLINE: Olive Oil, Phenols, Inflammatory Bowel Diseases, Cardiovascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NPOO project.
Abstract (Originalsprache)
High-phenolic extra-virgin olive oil (EVOO) is a chemically dynamic bioactive matrix in which cultivar, ripening stage, processing, storage, and digestion shape the final profile of phenolic alcohols and secoiridoids. In inflammatory bowel disease (IBD), chronic intestinal inflammation is associated with barrier dysfunction, dysbiosis, systemic immune activation, endothelial injury, platelet hyperreactivity, and increased cardiovascular risk. This narrative review evaluates whether EVOO phenolics may intersect the gut–endothelium–platelet axis linking IBD to vascular and thromboinflammatory complications. The review focuses on hydroxytyrosol, tyrosol, oleuropein- and ligstroside-derived secoiridoids, oleocanthal, and oleacein, with emphasis on their biosynthetic origin, processing-driven transformations, bioavailability, metabolism, and biological targets. Current evidence supports plausible effects on epithelial barrier integrity, TLR4/NF-κB signalling, Nrf2-mediated antioxidant defence, oxidised LDL formation, endothelial activation, and platelet-related pathways. Nevertheless, direct clinical evidence in IBD patients remains limited, and most cardiovascular-relevant findings are extrapolated from non-IBD human trials, animal studies, or in vitro models. Chemically characterised, biomarker-anchored intervention trials are needed before high-phenolic EVOO can be considered a validated strategy for modifying cardiovascular risk in IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathophysiology, University of Split School of Medicine, 21000 Split, Croatia.
- Laboratory for Cardiometabolic Research, University of Split School of Medicine, 21000 Split, Croatia.
- Department of Public Health, University of Split School of Medicine, 21000 Split, Croatia.
- Department of Anesthesiology and Intensive Care, University Hospital of Split, Spinciceva 1, 21000 Split, Croatia.
ORCID-Profile: Roko Šantić, Marko Kumrić, Marino Vilović, Joško Božić
Förderung
- NPOO project
Zitieren
APA
Šantić, R., Kumrić, M., Martinović, L., Vilović, M., Jerončić Tomić, I., Cvitković, I., & Božić, J. (2026). Extra-Virgin Olive Oil Phenolics in IBD-Associated Vascular Risk. Molecules, 31(11), 1827. https://doi.org/10.3390/molecules31111827
Vancouver
Šantić R, Kumrić M, Martinović L, Vilović M, Jerončić Tomić I, Cvitković I, et al. Extra-Virgin Olive Oil Phenolics in IBD-Associated Vascular Risk. Molecules. 2026;31(11):1827. doi:10.3390/molecules31111827
BibTeX
@article{anti2026,
author = {Šantić, Roko and Kumrić, Marko and Martinović, Lovre and Vilović, Marino and Jerončić Tomić, Iris and Cvitković, Ivan and Božić, Joško},
title = {Extra-Virgin Olive Oil Phenolics in IBD-Associated Vascular Risk},
journal = {Molecules},
year = {2026},
volume = {31},
number = {11},
pages = {1827},
doi = {10.3390/molecules31111827}
}
EUVIMED